Periostin suppression induces decorin secretion leading to reduced breast cancer cell motility and invasion

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Ishiba, Toshiyuki ^a   Nagahara, Makoto ^a   Nakagawa, Tsuyoshi ^a   Sato, Takanobu ^a   Ishikawa, Toshiaki ^a   Uetake, Hiroyuki ^a   Sugihara, Kenichi ^a   Miki, Yoshio ^a,b   Nakanishi, Akira ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b CANCER INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; DECORIN; POSTN PROTEIN, HUMAN;

ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BREAST TUMOR; CELL MOTION; CYSTOSARCOMA PHYLLOIDES; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; PATHOLOGY; SECRETION (PROCESS); STROMA CELL; TUMOR CELL LINE; TUMOR INVASION; TUMOR MICROENVIRONMENT;

BREAST NEOPLASMS; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL MOVEMENT; DECORIN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; PHYLLODES TUMOR; STROMAL CELLS; TUMOR MICROENVIRONMENT;

EID: 84945332027     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep07069     Document Type: Article

References (43)

1. Gupta, G. P. & Massague, J. Cancer metastasis: Building a framework. Cell 127, 679-695; DOI:10.1016/j.cell.2006.11.001 (2006).
2. Joyce, J. A. & Pollard, J. W. Microenvironmental regulation of metastasis. Nature Rev. Cancer 9, 239-252; DOI:10.1038/nrc2618 (2009).
3. Shibue, T. &Weinberg, R. A. Metastatic colonization: Settlement, adaptation and propagation of tumor cells in a foreign tissue environment. Semin. Cancer Biol. 21, 99-106; DOI:10.1016/j.semcancer.2010.12.003 (2011).
4. Malanchi, I. et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 481, 85-U95; DOI:10.1038/nature10694 (2012).
5. Merline, R. et al. Signaling by the Matrix Proteoglycan Decorin Controls Inflammation and Cancer Through PDCD4 andMicroRNA-21. Science Signaling 4, ra75; DOI:10.1126/scisignal.2001868 (2011).
6. Wu, S. et al. Silencing of periostin inhibits nicotine-mediated tumor cell growth and epithelial-mesenchymal transition in lung cancer cells. Mol. Med. Rep. 7, 875-880; DOI:10.3892/mmr.2013.1267 (2013).
7. Ouyang, G. et al.Upregulated expression of periostin by hypoxia in non-small-cell lung cancer cells promotes cell survival via the Akt/PKB pathway. Cancer Lett. 281, 213-219; DOI:10.1016/j.canlet.2009.02.030 (2009).
8. Bao, S. et al. Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell 5, 329-339; DOI:10.1016/S1535-6108(04)00081-9 (2004).
9. Tilman, G., Mattiussi, M., Brasseur, F., van Baren, N. & Decottignies, A. Human periostin gene expression in normal tissues, tumors and melanoma: evidences for periostin production by both stromal and melanoma cells. Mol. Cancer 6, 80; DOI:10.1186/1476-4598-6-80 (2007).
10. Baril, P. et al. Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta(4) integrin and the PI3k pathway. Oncogene 26, 2082-2094; DOI:10.1038/sj.onc.1210009 (2007).
11. Fluge, O., Bruland, O., Akslen, L., Lillehaug, J. & Varhaug, J. Gene expression in poorly differentiated papillary thyroid carcinomas. Thyroid 16, 161-175 (2006).
12. Ismail, R. et al. Differential gene expression between normal and tumor-derived ovarian epithelial cells. Cancer Res. 60, 6744-6749 (2000).
13. Shao, R. et al. Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Mol. Cell. Biol. 24, 3992-4003; DOI:10.1128/ MCB.24.9.3992-4003.2004 (2004).
14. Tischler, V. et al. Periostin is up-regulated in high grade and high stage prostate cancer. BMC Cancer 10, 273; DOI:10.1186/1471-2407-10-273 (2010).
15. Siriwardena, B. S. M. S. et al. Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer. Br. J. Cancer 95, 1396-1403; DOI:10.1038/sj.bjc.6603431 (2006).
16. Li, B., Wang, L. & Chi, B. Upregulation of periostin prevents P53-mediated apoptosis in SGC-7901 gastric cancer cells. Mol. Biol. Rep. 40, 1677-1683; DOI:10.1007/s11033-012-2218-3 (2013).
17. Gillan, L. et al. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(v)/beta(3) and alpha(v)beta(5) integrins and promotes cell motility. Cancer Res. 62, 5358-5364 (2002).
18. Kikuchi, Y. et al. The niche component periostin is produced by cancer-associated fibroblasts, supporting growth of gastric cancer through ERK activation. Am. J. Pathol. 184, 859-870. DOI: 10.1016/j.ajpath.2013.11.012 (2014).
19. Kikuchi, Y. et al. Periostin is expressed in pericryptal fibroblasts and cancerassociated fibroblasts in the colon. J. Histochem Cytochem. 56, 753-764. DOI: 10.1369/jhc.2008.951061 (2008).
20. Leygue, E. et al. Lumican and decorin are differentially expressed in human breast carcinoma. J. Pathol. 192, 313-320 (2000).
21. Ishiwata, T. et al. Role of lumican in cancer cells and adjacent stromal tissues in human pancreatic cancer. Oncol. Rep. 18, 537-543 (2007).
22. Edwards, I. J. Proteoglycans in prostate cancer. Nat. Rev. Urol. 9, 196-206; DOI:10.1007/s11033-012-2218-3 (2012).
23. Grant, D. et al. Decorin suppresses tumor cell-mediated angiogenesis. Oncogene 21, 4765-4777; DOI:10.1038/sj.onc.1205595 (2002).
24. Keene, D. et al. Acceleracted publication - Decorin binds near the C terminus of type I collagen. J. Biol. Chem. 275, 21801-21804; DOI:10.1074/jbc.C000278200 (2000).
25. Neame, P., Kay, C., McQuillan, D., Beales, M. & Hassell, J. Independent modulation of collagen fibrillogenesis by decorin and lumican. Cell. Mol. Life Sci. 57, 859-863; DOI:10.1007/s000180050048 (2000).
26. Geng, Y., McQuillan, D. & Roughley, P. J. SLRP interaction can protect collagen fibrils from cleavage by collagenases. Matrix Biol. 25, 484-491; DOI:10.1016/ j.matbio.2006.08.259 (2006).
27. Santra, M., Reed, C. & Iozzo, R. Decorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping but distinct from the EGFbinding epitope. J. Biol. Chem. 277, 35671-35681; DOI:10.1074/jbc.M205317200 (2002).
28. Wu, H. et al. Regulation of Intracellular Decorin via Proteasome Degradation in Rat Mesangial Cells. J. Cell. Biochem. 111, 1010-1019; DOI:10.1002/jcb.22789 (2010).
29. Yamaguchi, Y., Mann, D. M.&Ruoslahti, E. Negative Regulation of Transforming Growth-Factor-Beta by the Proteoglycan Decorin. Nature 346, 281-284; DOI:10.1038/346281a0 (1990).
30. Neill, T. et al. Decorin Antagonizes the Angiogenic Network: concurrent inhibition of Met, hypoxia inducible factor 1a, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3. J. Biol. Chem. 287, 5492-5506; DOI:10.1074/jbc.M111.283499 (2012).
31. Honda, E. & Munakata, H. Purification and characterization of decorin from the culture media of MRC-5 cells. Int. J. Biochem. Cell Biol. 36, 1635-1644; DOI:10.1016/j.biocel.2004.01.023 (2004).
32. Goldoni, S. et al. An antimetastatic role for decorin in breast cancer. Am. J. Pathol. 173, 844-855; DOI:10.2353/ajpath.2008.080275 (2008).
33. Dumont, N. et al. Breast Fibroblasts Modulate Early Dissemination, Tumorigenesis, and Metastasis through Alteration of Extracellular Matrix Characteristics. Neoplasia 15, 249-262 (2013).
34. Kalluri, R. & Zeisberg, M. Fibroblasts in cancer. Nature Rev. Cancer 6, 392-401; DOI:10.1038/nrc1877 (2006).
35. Ji, J. et al. Comparative proteomic analysis of rat hepatic stellate cell activation: A comprehensive view and suppressed immune response. Hepatology 56, 332-349; DOI: 10.1002/hep.25650. (2012).
36. Bao, S. et al. Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell 5, 329-339; DOI:10.1016/S1535-6108(04)00081-9 (2004).
37. Soltermann, A. et al. Prognostic Significance of Epithelial-Mesenchymal and Mesenchymal-Epithelial Transition Protein Expression in Non-Small Cell Lung Cancer. Clin. Cancer Res. 14, 7430-7437; DOI:10.1158/1078-0432.CCR-08-0935 (2008).
38. Bi, X. et al. Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in mice. Carcinogenesis 33, 326-330; DOI:10.1093/carcin/bgr293 (2012).
39. Michaylira, C. Z. et al. Periostin, a Cell Adhesion Molecule, Facilitates Invasion in the TumorMicroenvironment and Annotates a Novel Tumor-Invasive Signature in Esophageal Cancer. Cancer Res. 70, 5281-5292; DOI:10.1158/0008-5472.CAN- 10-0704 (2010).
40. Zhu, M. et al. Neutralizing Monoclonal Antibody to Periostin Inhibits Ovarian Tumor Growth and Metastasis. Mol. Cancer Ther. 10, 1500-1508; DOI:10.1158/ 1535-7163.MCT-11-0046 (2011).
41. Oda, G. et al. Significance of stromal decorin expression during the progression of breast cancer. Oncol. Rep. 28, 2003-2008; DOI:10.3892/or.2012.2040 (2012).
42. Reed, C. et al. Decorin prevents metastatic spreading of breast cancer. Oncogene 24, 1104-1110; DOI:10.1038/sj.onc.1208329 (2005).
43. Augoff, K. et al. Expression of Decorin in Esophageal Cancer in Relation to the Expression of Three Isoforms of Transforming Growth Factor-Beta (TGF-1, -2, and-3) and Matrix Metalloproteinase-2 Activity. Cancer Invest. 27, 443-452; DOI:10.1080/07357900802527221 (2009).